Published in Obesity and Diabetes Week, October 9th, 2006
In a recent review, scientists in England conducted a review "to summarize recent and ongoing randomized trials of statin therapy for the prevention of major vascular events. Four large-scale randomized trials have compared high-dose vs. standard doses of statin therapy among patients with coronary heart disease, and their results suggest that higher doses are more effective for preventing major vascular events, albeit with evidence of increased toxicity."
P.M. Kearney and C. Baigent working with the Clinic Trial Service Unit summarized, "There is now clear evidence that statin therapy is...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.